Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma".
Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma". Research Abstract Details
Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma". Abstract Text:
Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma". Publishing Authors By Initials
Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma". Journal Published:
PUBLICATION TYPE: Research Support, N.I.H., Extr
Journal: Journal of immunology (Baltimore, Md. : 1950)
VOLUME: 176
Page Numbers: 4511; author reply 4511-2
Journal Abbreviation: J. Immunol.
ISSN: 0022-1767
DAY: 15
MONTH: Apr
YEAR: 2006
Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma". Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 2985117
Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma". Keywords Mesh Terms:
KEYWORDS: Recurrence
MESH TERMS: therapy
Chemical & Substance for Abstract: Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma". Information
Substance Name: Cancer Vaccines
Registry Number: 0
Grant and Affiliation Information for Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma".
AFFILIATION:
Country: United States
AGENCY: United States NCI
GRANT: R01 CA104757-02
ACRONYM: CA
MEDLINETA: J Immunol
REFSOURCE: J Immunol. 2005 Nov 1;175(9):6169-76
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Comment on "Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma" Related Publications